A Randomized Phase III Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer
Phase of Trial: Phase III
Latest Information Update: 29 Aug 2017
At a glance
- Drugs Enoxaparin sodium (Primary) ; Carboplatin; Cisplatin; Etoposide
- Indications Small cell lung cancer
- Focus Therapeutic Use
- Acronyms RASTEN
- 24 Aug 2017 Status changed from active, no longer recruiting to completed.
- 13 Sep 2016 Planned End Date changed from 1 Apr 2017 to 1 Jun 2017.
- 13 Sep 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Jun 2017.